NexImmune, Inc. (NASDAQ:NEXI – Get Free Report)’s stock price traded down 15.2% on Friday . The stock traded as low as $0.10 and last traded at $0.10. 23,248 shares were traded during mid-day trading, an increase of 5% from the average session volume of 22,074 shares. The stock had previously closed at $0.12.
NexImmune Price Performance
The firm has a market capitalization of $139,639.50, a price-to-earnings ratio of -0.01 and a beta of 1.68. The business’s 50 day moving average price is $0.25 and its 200-day moving average price is $0.83.
NexImmune Company Profile
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
See Also
- Five stocks we like better than NexImmune
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- The How and Why of Investing in Gold Stocks
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
